Valuation EyePoint, Inc. Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate 13:46:30 2026-08-21 EDT			5-day change	1st Jan Change
4.370 ^EUR	-15.15%		-60.53%	-70.26%

08-18	EyePoint Faces Regulatory Uncertainty After Lugano Trial Miss, RBC Capital Markets Says	MT
08-18	Chardan Downgrades EyePoint Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $5 From $65	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	414.9	119.3	1,088	522.7	1,513	465.5	-	-
Change	-	-71.25%	811.96%	-51.95%	189.37%	-69.22%	-	-
Enterprise Value (EV) ¹	414.9	119.3	806.6	423	1,411	142.8	151.1	-515.9
Change	-	-71.25%	576.18%	-47.56%	233.51%	-89.88%	5.84%	-441.46%
P/E	-6.03x	-1.28x	-12.7x	-3.21x	-5.76x	-1.47x	-2.03x	-2.33x
PBR	-	-	4.26x	1.25x	4.37x	1.98x	2.5x	1.08x
PEG	-	-0x	0.4x	-0.1x	-0.2x	-0.1x	0.1x	0.2x
Capitalization / Revenue	11.2x	2.88x	23.6x	12.1x	48.2x	271x	26x	2.37x
EV / Revenue	11.2x	2.88x	17.5x	9.77x	45x	83x	8.43x	-2.63x
EV / EBITDA	-	-	-77.5x	-3.93x	-6.62x	-0.37x	-0.4x	3.58x
EV / EBIT	-7.51x	-1.51x	-10.7x	-2.9x	-5.8x	-0.39x	-0.47x	2.33x
EV / FCF	-8.26x	-1.78x	-502x	-3.25x	-5.8x	-0.49x	-0.51x	2.07x
FCF Yield	-12.1%	-56.3%	-0.2%	-30.8%	-17.3%	-205%	-196%	48.3%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2.03	-2.74	-1.82	-2.32	-3.17	-3.679	-2.665	-2.316
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	36.94	41.4	46.02	43.27	31.37	1.72	17.92	196.3
EBITDA ¹	-	-	-10.4	-107.6	-213.3	-380.7	-376.1	-144.1
EBIT ¹	-55.28	-78.94	-75.07	-145.9	-243.4	-361.7	-321.4	-221.5
Net income ¹	-58.42	-102.3	-70.8	-130.9	-232	-344.6	-292	-258
Net Debt ¹	-	-	-281.3	-99.7	-101.8	-322.8	-314.5	-981.5
Reference price ²	12.240	3.500	23.110	7.450	18.270	5.400	5.400	5.400
Nbr of stocks (in thousands)	33,894	34,083	47,074	70,160	82,787	86,212	-	-
Announcement Date	3/3/22	3/2/23	3/7/24	3/5/25	3/4/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.55x	12.84x	26.06x	0.55%	1,109B
JOHNSON & JOHNSON	29.74x	-	-	2.01%	644B
ABBVIE INC.	33.42x	7.74x	16.11x	2.62%	463B
ROCHE HOLDING AG	20.72x	4.91x	12.16x	2.69%	371B
NOVARTIS AG	22.47x	5.78x	14.33x	2.76%	301B
ASTRAZENECA PLC	21.12x	4.35x	12.35x	2.02%	256B
AMGEN INC.	27.43x	7.09x	12.59x	2.33%	234B
NOVO NORDISK A/S	13.47x	4.79x	10.05x	3.81%	205B
GILEAD SCIENCES, INC.	-43.83x	6.34x	24.76x	2.3%	178B
Average	17.79x	6.73x	16.05x	2.34%	417.9B
Weighted average by Cap.	25.34x	8.43x	18.53x	1.91%